Easy to use, this product is developed by Sato Pharmaceutical Co., Ltd., a famous Japanese pharmaceutical company with a century history, and is an anti-aging skin care brand. The following is a relevant introduction about excelllula: Excellla is a skin care product brand owned by Sato Pharmaceutical Co., Ltd., registered on December 28, 2012, and the trademark registration number is 9991047.
Hi Esnoona. According to the relevant public information, Esnonna has been firmly on the throne of skin care products with the highest repurchase rate in Japanese pharmacies for many years. It can make the foundation stick to the face better without adding a powdery feel, while Olay has a mediocre effect. Much worse in comparison.
Hi Esnoona. Esnonna is a mid-range brand with good reputation and large sales volume, while Jiaomasi's sales volume is not large, so it is a niche brand. The effect of Esnonna is obvious and it is suitable for people of all skin types. However, Jiaomaz varies from person to person and is not suitable for everyone.
Elisel is easy to use. ELIXIR, a skin anti-aging brand born in Japan in 1983, possesses Shiseido's cutting-edge anti-aging technology. Shiseido ELIXIR is based on the "skin beautification and reactivation theory" and is developed to target adverse skin conditions caused by skin oxidation. comprehensive range of skin care products.
The main functions of Esnonna’s skin care products are hydration, deep repair, firming and lightening of wrinkles. Esnonna’s Moisturizing and Slow-release Base Essence Water is really effective and provides continuous hydration. It has strong moisturizing ability and has the effect of repairing the skin, repairing the basement membrane and making the skin healthier.
Simple and beautiful: Esnonna adopts a simple design style, with exquisite and beautiful appearance, which is very suitable for use at home or in the office. Esnonna can also be remotely controlled through the mobile APP, making it convenient for users to control smart home devices anytime and anywhere.